# INTERVIEW: Proteome Sciences plc A key year that’s started well

- Link: https://www.directorstalkinterviews.com/interview-proteome-sciences-plc-key-year-thats-started-well/412726320
- Published: 2017-03-29T07:29:32+01:00
- Author: Giles Arbor

**Proteome Sciences plc** (LON:PRM) Chief Executive Officer Jeremy Haigh talks to
DirectorsTalk about it’s positive year end results. With a 46% jump in revenues 
for last year, Jeremy explains what the key drivers were behind this, more about
it’s twin pronged growth strategy – in proteomics and bioinformatics, how the company
will benefit from a trend in ‘personalised medicine’ and what we should expect for
the rest of the year.

 

Proteome Sciences Plc is a leader in applied proteomics offering high sensitivity,
proprietary technologies and workflows for mapping cell signalling pathways (SysQuant
®, TMTcalibrator™) and for the discovery, validation and assay development of protein
biomarkers. The company has its headquarters in Cobham, UK, with laboratory facilities
in London, UK and in Frankfurt, Germany from where the PS Biomarker Services™ division
provides outsourced proteomics services and proprietary biomarker assays to biopharmaceutical
and diagnostics companies, and to academia. The company has patented a series of
novel protein biomarkers for diagnostic and treatment applications in important 
areas of human therapeutics such as cancer, stroke and Alzheimer’s disease, and 
these are also available for license.

Share on: